Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Heideman

Showing results (211-220 of 272) with videos related to

Pageof 28
Sort By:
Lung Cancer (Amsterdam, Netherlands)|January 12, 2020
Osimertinib treatment for patients with EGFR exon 20 mutation positive non-small cell lung cancerB van Veggel, J F Vilacha Madeira R Santos, S M S Hashemi, et al.
International Journal of Cancer|September 24, 2021
Performance of DNA methylation analysis of ASCL1, LHX8, ST6GALNAC5, GHSR, ZIC1 and SST for the triage of HPV-positive women: Results from a Dutch primary HPV-based screening cohortLisanne Verhoef, Maaike C G Bleeker, Nicole Polman, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 11, 2013
High-risk human papillomavirus-positive lung cancer: molecular evidence for a pattern of pulmonary metastasisRobert A A van Boerdonk, Johannes M A Daniels, Elisabeth Bloemena, et al.
Journal of Clinical Pathology|June 12, 2014
Combined sputum hypermethylation and eNose analysis for lung cancer diagnosisA Jasmijn Hubers, Paul Brinkman, Remco J Boksem, et al.
International Journal of Cancer|November 9, 2023
High-risk human papillomavirus distribution according to human immunodeficiency virus status among women with cervical cancer in Abidjan, Côte d'Ivoire, 2018 to 2020Simon P Boni, Vanessa Tenet, Apollinaire Horo, et al.
Journal of Clinical Microbiology|August 8, 2008
Comparison of GP5+/6+-PCR and SPF10-line blot assays for detection of high-risk human papillomavirus in samples from women with normal cytology results who develop grade 3 cervical intraepithelial neoplasiaA T Hesselink, M A P C van Ham, D A M Heideman, et al.
Oncotarget|May 28, 2015
NF-κB drives acquired resistance to a novel mutant-selective EGFR inhibitorElena Galvani, Jing Sun, Leticia G Leon, et al.
Plos One|August 31, 2017
Overall survival in EGFR mutated non-small-cell lung cancer patients treated with afatinib after EGFR TKI and resistant mechanisms upon disease progressionA J van der Wekken, J L Kuiper, A Saber, et al.
Lung Cancer (Amsterdam, Netherlands)|February 18, 2014
EGFR mutated non-small cell lung cancer patients: more prone to development of bone and brain metastases?L E L Hendriks, E F Smit, B A H Vosse, et al.
Cancer Medicine|July 22, 2018
Molecular heterogeneity in human papillomavirus-dependent and -independent vulvar carcinogenesisDorian R A Swarts, Quirinus J M Voorham, Annina P van Splunter, et al.
Pageof 28

Showing results (211-220 of 272) with videos related to

Sort By:
Pageof 28
Lung Cancer (Amsterdam, Netherlands)|January 12, 2020
Osimertinib treatment for patients with EGFR exon 20 mutation positive non-small cell lung cancerB van Veggel, J F Vilacha Madeira R Santos, S M S Hashemi, et al.
International Journal of Cancer|September 24, 2021
Performance of DNA methylation analysis of ASCL1, LHX8, ST6GALNAC5, GHSR, ZIC1 and SST for the triage of HPV-positive women: Results from a Dutch primary HPV-based screening cohortLisanne Verhoef, Maaike C G Bleeker, Nicole Polman, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 11, 2013
High-risk human papillomavirus-positive lung cancer: molecular evidence for a pattern of pulmonary metastasisRobert A A van Boerdonk, Johannes M A Daniels, Elisabeth Bloemena, et al.
Journal of Clinical Pathology|June 12, 2014
Combined sputum hypermethylation and eNose analysis for lung cancer diagnosisA Jasmijn Hubers, Paul Brinkman, Remco J Boksem, et al.
International Journal of Cancer|November 9, 2023
High-risk human papillomavirus distribution according to human immunodeficiency virus status among women with cervical cancer in Abidjan, Côte d'Ivoire, 2018 to 2020Simon P Boni, Vanessa Tenet, Apollinaire Horo, et al.
Journal of Clinical Microbiology|August 8, 2008
Comparison of GP5+/6+-PCR and SPF10-line blot assays for detection of high-risk human papillomavirus in samples from women with normal cytology results who develop grade 3 cervical intraepithelial neoplasiaA T Hesselink, M A P C van Ham, D A M Heideman, et al.
Oncotarget|May 28, 2015
NF-κB drives acquired resistance to a novel mutant-selective EGFR inhibitorElena Galvani, Jing Sun, Leticia G Leon, et al.
Plos One|August 31, 2017
Overall survival in EGFR mutated non-small-cell lung cancer patients treated with afatinib after EGFR TKI and resistant mechanisms upon disease progressionA J van der Wekken, J L Kuiper, A Saber, et al.
Lung Cancer (Amsterdam, Netherlands)|February 18, 2014
EGFR mutated non-small cell lung cancer patients: more prone to development of bone and brain metastases?L E L Hendriks, E F Smit, B A H Vosse, et al.
Cancer Medicine|July 22, 2018
Molecular heterogeneity in human papillomavirus-dependent and -independent vulvar carcinogenesisDorian R A Swarts, Quirinus J M Voorham, Annina P van Splunter, et al.
Pageof 28